Previous 10 | Next 10 |
2024-04-15 16:08:10 ET Summary Given the huge and growing GLP-1 weight loss market, recent trial data from Viking Therapeutics could make it a potential acquisition target for a larger concern. While many bigger pharma names might desire entry into the huge GLP-1 weight loss marke...
2024-04-15 10:00:00 ET Sometimes it pays to team up. That's what Novo Nordisk (NYSE: NVO) and Ginkgo Bioworks (NYSE: DNA) decided to do April 10 when they launched a new manufacturing collaboration that could benefit both companies. Details about the financial terms of their...
2024-04-12 12:02:53 ET More on AbbVie, Biogen, etc. AbbVie: Despite The Run, Shares Still Look Attractive, Yielding 3.67% Novo Nordisk: The Moat Won't Last Forever AbbVie: Still Fits Buffett's 10x EBT Rule Well Despite Guidance Revision No link between weight...
2024-04-12 09:00:00 ET U.S. stock index futures on Friday pointed to a lower open, with the spotlight squarely on quarterly reports from major lenders and financial firms. Here are some stocks to watch on Friday: ... Read the full article on Seeking Alpha For further de...
2024-04-12 07:05:43 ET More on Eli Lilly, Novo Nordisk, etc. Novo Nordisk: The Moat Won't Last Forever Eli Lilly: Three Threats To Its Huge Rally Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss Data Roche, Eli Lilly gain ...
2024-04-12 05:00:04 ET Evan David Seigerman from BMO Capital issued a price target of $163.00 for NVO on 2024-04-12 04:05:00. The adjusted price target was set to $163.00. At the time of the announcement, NVO was trading at $125.4. NVO currently trades -37.84% versus its...
2024-04-10 12:30:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. We believe internation...
2024-04-10 07:34:44 ET More on Ginkgo Bioworks Ginkgo Bioworks: Multiple Red Flags Ginkgo Bioworks: More Awful Revenue Guidance Ginkgo Bioworks Holdings, Inc. 2023 Q4 - Results - Earnings Call Presentation Ginkgo Bioworks acquires cell therapy assets from Mod...
2024-04-10 07:15:00 ET The healthcare business never sleeps and never goes out of style. That's one of the advantages of investing in stocks in this sector. But to be successful at it, it's important to pick innovative companies that benefit from an economic moat, are leaders in their respe...
2024-04-10 06:45:00 ET Novo Nordisk (NYSE: NVO) has become one of the most valuable healthcare stocks in the world, largely due to a couple of exceptional drugs, Ozempic and Wegovy. While the former is a diabetes drug and the latter is approved for weight loss, consumers have been u...
News, Short Squeeze, Breakout and More Instantly...
Novo Nordisk A/S Company Name:
NVO Stock Symbol:
NYSE Market:
Online pharmacies and slimming clinics in Britain are reducing prices for Novo Nordisk A/S’s (NYSE:NVO) Wegovy and&n...
2024-05-02 13:00:13 ET Image source: The Motley Fool. Novo Nordisk (NYSE: NVO) Q1 2024 Earnings Call May 02, 2024 , 7:00 a.m. ET Operator Continue reading For further details see: Novo Nordisk (NVO) Q1 2024 Earnings Call Transcript
2024-05-02 10:18:21 ET The biotech sector includes companies that utilize biological processes to develop technologies and products for a wide range of industries. This includes healthcare, agriculture, and environmental management. These companies often focus on innovative therapies, medic...